Novartis Ireland Limited (Novartis Ireland Limited)
Lobbying activity
The following activities occurred for this specific Subject Matter Area.
Meeting (2-5)
One to one meetings to talk through the recommendations of recent HPP Report on advanced cancer therapies and in particular radioligand therapy. Locations included Buswells, Cork and one meeting in Leinster House.
Phone call (2-5)
Follow up phone calls to discuss the topic further
Email (11-20)
Sharing information on the topic
Event / Reception (1)
Health Tech Ireland Forum in RCSI - discussed access to innovation and advanced therapies during the Q&A session
Event / Reception (1)
All Island Cancer Summit on the 19th May in Croke Park, HPP white paper on advanced therapies launched. Shared the report with DPOs after the event.
Event / Reception (1)
Attended evening in Leinster House with Dublin Chamber of Commerce and discussed the importance of valuing innovation in government policy with some attendees.
Informal communication (1)
Brief conversations at the US Ambassadors Independence Day evening, July 2026.
Designated public officials lobbied
The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.